Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Affiliation country
Publication year range
1.
Br J Cancer ; 105(12): 1839-49, 2011 Dec 06.
Article in English | MEDLINE | ID: mdl-22045192

ABSTRACT

BACKGROUND: Hyaluronan (HA) plays crucial roles in the tumourigenicity of many types of malignant tumours. 4-Methylumbelliferone (MU) is an inhibitor of HA synthesis. Several studies have shown its inhibitory effects on malignant tumours; however, none have focused on its effects on osteosarcoma. METHODS: We investigated the effects of MU on HA accumulation and tumourigenicity of highly metastatic murine osteosarcoma cells (LM8) that have HA-rich cell-associated matrix, and human osteosarcoma cell lines (MG-63 and HOS). RESULTS: In vitro, MU inhibited HA retention, thereby reducing the formation of functional cell-associated matrices, and also inhibited cell proliferation, migration, and invasion. Akt phosphorylation was suppressed by MU (1.0 mM). In vivo, although MU showed only a mild inhibitory effect on the growth of the primary tumour, it markedly inhibited (75% reduction) the development of lung metastasis. Hyaluronan retention in the periphery of the primary tumour was markedly suppressed by MU. CONCLUSION: These findings suggested that MU suppressed HA retention and cell-associated matrix formation in osteosarcoma cells, resulting in a reduction of tumourigenicity, including lung metastasis. 4-Methylumbelliferone is a promising therapeutic agent targeting both primary tumours and distant metastasis of osteosarcoma, possibly via suppression of HA retention.


Subject(s)
Hyaluronic Acid/metabolism , Hymecromone/analogs & derivatives , Lung Neoplasms/secondary , Osteosarcoma/pathology , Apoptosis/drug effects , Cell Cycle , Cell Line, Tumor , Cell Proliferation/drug effects , Humans , Hyaluronic Acid/antagonists & inhibitors , Hymecromone/pharmacology , Immunohistochemistry , In Situ Nick-End Labeling , In Vitro Techniques , Lung Neoplasms/metabolism , Osteosarcoma/metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , Real-Time Polymerase Chain Reaction
2.
Oncogene ; 15(20): 2483-92, 1997 Nov 13.
Article in English | MEDLINE | ID: mdl-9395244

ABSTRACT

Human retinoblastoma (Rb) protein, immunopurified from an extract of recombinant baculovirus infected cells, stimulated 10-100-fold the activity of DNA polymerase alpha from calf thymus or human HeLa cells. Purified Rb protein is composed of two electrophoretically distinguishable forms, i.e., partially phosphorylated and under-phosphorylated forms. Dephosphorylation of Rb protein by protein phosphatase 2A largely diminished its stimulatory effect. On the other hand, a hyperphosphorylated Rb protein, obtained from insect cells overexpressing Rb protein, cyclin E and cyclin-dependent kinase 2 simultaneously, stimulated DNA polymerase alpha more strongly than the singly-expressed Rb protein. These results indicate that the phosphorylation is crucial for the stimulation. Rb protein isolated from human Burkitt lymphoma Raji cells also stimulated DNA polymerase alpha. In contrast, Rb protein did not affect eukaryotic DNA primase or Klenow fragment of Escherichia coli DNA polymerase I. By immunoprecipitation using anti-DNA polymerase alpha antibody, Rb protein in nuclear extract of Raji cells was co-precipitated with DNA polymerase alpha. This result indicates that DNA polymerase alpha exists as a complex containing phosphorylated Rb protein in cells. DNA polymerase alpha specifically bound to a purified Rb protein-immobilized Sepharose column. Rb protein also bound to DNA polymerase alpha trapped to anti-DNA polymerase alpha antibody-Sepharose column, suggesting the direct association of these two proteins. These observations suggest a new function of phosphorylated Rb protein in the regulation of DNA replication.


Subject(s)
DNA Polymerase I/metabolism , Retinoblastoma Protein/pharmacology , Burkitt Lymphoma/pathology , Chromatography, Affinity , Cyclin E/metabolism , DNA Polymerase I/immunology , DNA Replication , DNA-Directed DNA Polymerase/metabolism , Enzyme Activation/drug effects , Humans , Neoplasm Proteins/metabolism , Phosphoprotein Phosphatases/metabolism , Phosphorylation , Protein Phosphatase 2 , Protein Processing, Post-Translational , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/pharmacology , Retinoblastoma Protein/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL